MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ALGS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Aligos Therapeutics (ALGS) Ownership - Who owns Aligos Therapeutics?

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
One Corporate Drive
Phone
+1 800 466-6059
Employees
82
Web
https://www.aligos.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
35.09M
P/E Ratio
N/A
Total Cash
54.91M
Projected Growth
N/A
Total Debt
4.35M
Revenue
4.71M
Risk (Beta)
2.14
Dividend Yield
N/A
Total Cash/Share
8.87
Total Debt/Equity
N/A
Revenue/Share
0.45 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ALGS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ALGS
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
One Corporate Drive
Phone
+1 800 466-6059
Employees
82
Web
https://www.aligos.com